{
  "chapter": "Carcinoma Cervix",
  "questions": [
    {
      "q_no": 1,
      "question": "Which serotype of HPV is responsible for carcinoma cervix?",
      "options": {
        "A": "6, 11 31, 32",
        "B": "16, 18, 31, 32",
        "C": "6, 11, 16, 18",
        "D": "16, 18, 31, 33"
      },
      "correct_answer": "D",
      "explanation": "",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 2,
      "question": "Which of the following is not true regarding HPV?",
      "options": {
        "A": "E1 and E2 are viral proteins needed for replication",
        "B": "E6 and E7 are viral proteins needed for malignant transformationE6 acts via the retinoblastoma gened) HPV 16 is the most common serotype causing carcinoma cervixQuestion 3:Which is the HPV serotype most commonly associated with carcinoma cervix?a) 16b) 18",
        "C": "31",
        "D": "33"
      },
      "correct_answer": "C",
      "explanation": "E6 acts via the tumor suppression gene p53. It increases proteasome-dependent p53degradation. E7 binds and acts via the retinoblastoma (Rb) gene.The viral E6 and E7 oncoproteins encoded by the high-risk type HPVs (such as HPV 16 and HPV18) are necessary for malignant transformation.E1 and E2 oncoproteins are responsible for viral replication.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 4,
      "question": "Which of the following is false about the Cervarix vaccine?",
      "options": {
        "A": "Protects against HPV types 16 and 18",
        "B": "Dose is 0.5ml, intramuscular",
        "C": "Protective against genital warts829",
        "D": "Dosing schedule - 0, 1 and 6 months"
      },
      "correct_answer": "",
      "explanation": "The Cervarix vaccine is not protective against genital warts. It is mainly protective against CINand cervical cancer.Vaccine TypeCervarixGardasilBivalent vaccineHPV typesHPV 16,18Quadrivalent vaccineHPV 6, 11, 16, 18Gardasil 9Nonavalent vaccine\"HPV 6, 11, 16, 18, 31, 33, 45,52, and 58DosageSchedule0.5 mL0.5 mL0.5 mL0, 1, 6 months0, 2, 6 months0, 2,6months838Vaccine TypeDiseases preventedCervarixCINCarcinoma cervixGardasilCINCarcinoma cervixGenitalwartsGardasil 9CINCarcinomacervixGenitalwarts VulvalcancerVaginalepithelial cancerOropharyngealcancerAdjuvantAS04AlumAlum",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 5,
      "question": "HPV nonavalent vaccine is active against which of the following serotypes?",
      "options": {
        "A": "6, 11, 16, 18, 20, 23, 35, 42, 52",
        "B": "6, 11, 16, 19, 23, 33, 45, 58",
        "C": "6, 11, 16, 18, 32, 34, 45, 52, 58",
        "D": "6, 11, 16, 18, 31, 33, 45, 52, 58"
      },
      "correct_answer": "D",
      "explanation": "HPV nonavalent vaccine (Gardasil 9 or HPV9) is active against HPV 6,11,16,18,31,33,45,52,58.Currently, HPV nonnavalent vaccine has replaced Gardasil which is a quadrivalent vaccine actingagainst 6,11,16,18.Vaccines available for HPV:Brand nameCervarixGardasilCharacteristic andBivalent:16,18Quadrivalent:6,11,1HPV subtypes6,18Protects against:CINCA cervixAnogenital wartsCINCA cervixGardasil-9CervavacIdeally at 11-12 years or9-26 yearsNonavalent:6,11,16,18,31,33,45,52,58Anogenital wartsCINCA cervixVulvalintraepithelialneoplasiaVaginalintraepithelialneoplasiaAnal cancerOropharyngea1 cancer Head and neck cancers0.5 ml,IM.Quadrivalent:6,11,16,18Anogenital wartsCINCA cervix0.5 ml,IM.Ideally at 11-12 years or9-26 yearsThe targeted age group is 9-26 yearsDose0.5 ml,IM.0.5 ml,IM.Ideal Age range:Ideally at 11-12 years or9-26 years",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 6,
      "question": "A 45-year-old patient comes with repeated infections of trichomonas vaginitis, her physicianadvises for a Pap smear. She asks you regarding the purpose of this test. What would be yourappropriate response?",
      "options": {
        "A": "It is a screening test for cervical cancer",
        "B": "It is a diagnostic test for trichomonas infection",
        "C": "It helps to diagnose cancer in her genital tract",
        "D": "It helps to diagnose other associated genital infections in her"
      },
      "correct_answer": "A",
      "explanation": "A pap smear is a screening test for cervical cancer. It is not a diagnostic test (option C). Thepresence of abnormal cells/ a positive test requires further evaluation by colposcopy, cervicalbiopsy, or fractional curettage.If trichomonas is reported from Pap testing, it should be confirmed by saline microscopicpreparation (option B).Cervical cancer screening should start at age 21. Women aged 21-29 should have a Pap smearevery 3 years, while women aged 30-65 should have both HPV and Pap co-test every 5years. Women should stop having cervical cancer screening after the age of 65 years. If suspiciousPAP, screening till 75 years. HIV+ women should have annual checkups until three consecutivenegative tests followed by testing every 3 years for life.839Pap testing should be done prior to vaginal examination. Lubricants should not be used andthe patient should not be menstruating during the pap test. The patient should not haveintercourse 24hrs prior to the test. The ideal time is around ovulation.Procedure:• The patient is put in a dorsal position, and the labia are parted• Cusco's self-retaining speculum is introduced• The squamocolumnar junction is scraped with Ayer's spatula:• Bifid end - ectocervical sample• Blunt end - vaginal cytology• Endocervix is scraped with a cytobrush• The sample is spread on a glass slide• The slide is immediately fixed using 95% ethyl alcohol• Stained with Papanicolau stain or short-duration Papanicolau stain (SPS).involvedColumn T san840Instruments used for Pap smearCusco's self-retainingbivalve speculumCervicalbroomAyrespatulaCytobrushSlide holding jar / Koplin jar©MARROW",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mobgy/exp6_img1_58c617b5.jpeg",
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 7,
      "question": "A 24-year-old woman comes to the gynecology OPD for a routine Pap smear. Thehistopathology slide is shown below. Identify the cell marked as \"A\".830",
      "options": {
        "A": "Superficial cell",
        "B": "Basal cellParabasal celld) Intermediate cellQuestion 8:Match the following:a) A-2, B-1, C-4, D-5, E-3b) A-2, B-1, C-4, D-3, E-5",
        "C": "A-1, B-2, C-4, D-5, E-3",
        "D": "A-2, B-1, C-3, D-5, E-4"
      },
      "correct_answer": "A",
      "explanation": "The cell marked A is the superficial cell.ACOG guidelines recommend cervical exfoliative cytology every 3 years starting 21 years asscreening for cervical cancer.The image below shows a superficial cell (a) and an intermediate cell (b):(a)(b)The image below shows parabasal cells (marked by black arrows):841Koilocytes are epithelial cells that contain eccentric, hyperchromatic, moderately enlarged nucleusthat is displaced by large perinuclear vacuole. It is a feature of HPV infection.",
      "image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mobgy/q7_img1_cf3c4698.jpeg",
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mobgy/exp7_img1_ed6c1dc1.jpeg",
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 9,
      "question": "A 45-year-old lady complains of post-coital bleeding. She has a positive pap smear. What isthe next line of management?",
      "options": {
        "A": "Colposcopy directed biopsy",
        "B": "Cone biopsy",
        "C": "Repeat pap smear",
        "D": "Hysterectomy831"
      },
      "correct_answer": "",
      "explanation": "The appropriate management of a 45-year-old with a positive pap smear and post-coital bleedingis a colposcopy-directed biopsy.A per speculum examination must be done whenever a female comes with post-coital bleeding inorder to evaluate for carcinoma of the cervix. If growth is visible, a punch biopsy should be done,and else if no growth is visible, then a pap smear is done. A pap smear is a screening test forcervical cancer. The presence of abnormal cells/ a positive test requires further evaluation bycolposcopy, cervical biopsy, or fractional curettage.Cervical cancer screening should start at age 21. Women aged 21-29 should have a pap smearevery 3 years, while women aged 30-65 should have both HPV and pap co-test every 5years. Women should stop having cervical cancer screening after the age of 65 years. If a papsmear is suspicious, then screening is continued till 75 years. HIV+ve women should have annualcheckups until three consecutive negative tests followed by testing every 3 years for life.Pap testing should be done prior to vaginal examination. Lubricants should not be used andthe patient should not be menstruating during the pap test. The patient should not haveintercourse 24hrs prior to the test. The ideal time is around ovulation.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 10,
      "question": "A 30-year-old sex worker presented with irregular menses, post-coital bleeding, andoccasional foul-smelling vaginal discharge. She was advised to undergo a Pap smear. What isthe best time for this investigation?",
      "options": {
        "A": "Immediately after menstruation",
        "B": "Around ovulation",
        "C": "Secretory phase",
        "D": "During menstruation"
      },
      "correct_answer": "",
      "explanation": "The given case scenario is suggestive of cervical carcinoma. The best time to do a Pap smear isaround ovulation, but it can be performed at any other time as well.Prerequisites of doing a Pap smear:• It should be done prior to vaginal examination⚫ Lubricants should not be used• The patient should not be menstruating during the pap test843• The ideal time is around ovulation• The patient should not have intercourse 24hrs prior to the test.Based on Pap smear findings, dysplasia of cervical cells is graded using various classificationsystems such as WHO grading, CIN grading, and the Bethesda system.MMild dysplasiaModerate dysplasiaSevere dysplasiInvasive squamousinsituAdenocarin orGM ARROW",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mobgy/exp10_img1_167a6a8b.jpeg",
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 11,
      "question": "Which of the following is false about Schiller's test?",
      "options": {
        "A": "Lugol's iodine is used to paint the cervix",
        "B": "The epithelium is stained mahogany brown",
        "C": "Abnormal vaginal epithelium is stained",
        "D": "It detects the presence of glycogen in the epithelium"
      },
      "correct_answer": "A",
      "explanation": "The abnormal cells remain unstained on performing Schiller's test.Schiller's test, also known as VILI (visual inspection with Lugol's iodine), involves painting thecervix with Lugol's iodine. It is used to detect any abnormal cytology in the cervix and vagina,such as in cases of carcinoma cervix.The normal vaginal and cervical epithelium contains glycogen, therefore stains mahogany brownon being painted with Lugol's iodine. The abnormal cells remain unstained. These areas need tobe biopsied and sent for histopathological examination.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 12,
      "question": "Which of the following would you not expect to see in the colposcopic biopsy of a patient withcervical intraepithelial neoplasia?",
      "options": {
        "A": "Dysplasia",
        "B": "Breach in basement membrane",
        "C": "Altered N:C ratio",
        "D": "Mitotic figures"
      },
      "correct_answer": "B",
      "explanation": "The basement membrane is intact in cervical intraepithelial neoplasia (CIN).Features of CIN:•Varying degree of dysplasia••Altered nuclear-cytoplasmic (N:C) ratioHyperchromatic nuclei• Mitotic figures•• Intact basement membrane.844",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 13,
      "question": "Which of the following methods is most commonly used for the treatment of CIN?",
      "options": {
        "A": "Cold-knife conization",
        "B": "Large loop excision of transformation zone",
        "C": "Electrocoagulation",
        "D": "Needle excision of transformation zone832"
      },
      "correct_answer": "B",
      "explanation": "Large loop excision of the transformation zone (LLETZ) is the most commonly used treatmentoption for cervical intraepithelial neoplasia (CIN). It is also known as loop electrosurgical excisionprocedure (LEEP).It is applicable for the treatment of CIN anywhere in the lower genital tract. This uses electriccurrent through a monopolar wire electrode to either cut or coagulate cervical lesions. Like otherexcisional procedures, it is done in the immediate post menstrual phase.The procedure involves minimal patient discomfort, cost, and complications. Since it can beperformed using local anesthesia, it has become the primary outpatient treatment modality forhigh-grade cervical lesions.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 14,
      "question": "Which among the following is the treatment of choice when microinvasion of cervix neoplasiais suspected?",
      "options": {
        "A": "LLTEZ",
        "B": "LEEP",
        "C": "Conization",
        "D": "Hysterectomy"
      },
      "correct_answer": "C",
      "explanation": "Conization is the treatment of choice when microinvasion is suspected.•Indications of conization• Endocervical dysplasia• Transformation zone is not completely visualized• When there is discrepancy of findings between cytolology, colposcopy &amp; biopsy• Microinvasion is suspected•Indications of hysterectomy• Older &amp; parous women• Uterus is associated with fibroid, DUB, prolapsed• Recurrence or persistent lesion• In-situ adenocarcinoma cervix",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 15,
      "question": "A 40-year-old woman has cervical intraepithelial neoplasia III. What would be themanagement?",
      "options": {
        "A": "Hysterectomy",
        "B": "Trachelectomy",
        "C": "Conization",
        "D": "Colposcopy with LEEP"
      },
      "correct_answer": "D",
      "explanation": "Colposcopy with LEEP would be appropriate management for CIN III.Loop electrosurgical excision procedure (LEEP) is an opd procedure done under colposcopic viewand local anesthesia. Here, a low voltage current is passed through the loop and a cone of tissue isremoved from the cervix. This procedure causes minimal bleeding and the tissue removed is sentfor histopathological examination (HPE). This is the treatment of choice for CIN 2&amp;3 of anyage and parity.845",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 16,
      "question": "Which is the most common malignancy in women in India?",
      "options": {
        "A": "Cervical cancer",
        "B": "Breast cancer",
        "C": "Endometrial cancer",
        "D": "Ovarian cancer"
      },
      "correct_answer": "B",
      "explanation": "Breast cancer is the most common cancer in women in India as well as globally. Cervical cancer isthe most common genital cancer in India.Lip and oral cavity cancer is the most common malignancy in men.Risk factors for carcinoma cervix include:• Human Papilloma virus (most important)• Sexual intercourse before 18 years.Multiple sexual partners• Multiparity• Poor personal hygiene• Smoking and drug abuse• Women with STD, HIV, HSV• Immune suppression",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 17,
      "question": "Which of the following is false regarding the transitional zone?",
      "options": {
        "A": "CIN originates from this site",
        "B": "It is a dynamic point",
        "C": "Nabothian cysts mark the original site833",
        "D": "It is limited to external os"
      },
      "correct_answer": "D",
      "explanation": "The transitional zone or squamocolumnar junction is well outside the external os during thereproductive period.It is the site where the squamous epithelium lining the vagina merges with the columnarepithelium of the endocervix. The original squamocolumnar junction is marked by the presence ofNabothian cysts and glandular openings.It is a dynamic part and moves with age and hormonal influence:•• During pregnancy and with oral contraceptives, it pouts out of os.• Following menopause, it gets indrawn inside the os.The cells here are highly sensitive to irritants, mutagens and viral agents such as HPV. Cancerscreening using Pap smear involves scraping this area and studying the cells for nuclear changes.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 18,
      "question": "Identify the false statement regarding adenocarcinoma of the cervix.",
      "options": {
        "A": "Most common site is transformation zone",
        "B": "Cervical cancer is the second most common cancer among women in India",
        "C": "Most common in OCP users",
        "D": "Associated with HPV 18"
      },
      "correct_answer": "A",
      "explanation": "The most common site of adenocarcinoma is endocervix.It commonly occurs in young females and OCP users, and is associated with HPV 18.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 19,
      "question": "You would suspect and evaluate for carcinoma cervix in patients presenting with which of thefollowing conditions?",
      "options": {
        "A": "Menorrhagia",
        "B": "Metrorrhagia",
        "C": "Polymenorrhea",
        "D": "Amenorrhea"
      },
      "correct_answer": "B",
      "explanation": "846Patients with carcinoma cervix most commonly present with metrorrhagia, now known asintermenstrual bleeding.Post-coital bleeding is the most specific symptom of carcinoma cervix.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 20,
      "question": "What is the most common site of hematogenous metastasis of cervical cancer?",
      "options": {
        "A": "Lung",
        "B": "Liver",
        "C": "Bone",
        "D": "Bowel"
      },
      "correct_answer": "A",
      "explanation": "The most common site of hematogenous metastasis of cervical cancer is the lung.About 1-2% of patients with cervical carcinomas present with lung metastases, and 5-35%eventually develop lung metastases.Other common sites of blood-borne metastases include bone, liver and bowel.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 21,
      "question": "A 65-year-old woman comes for follow-up a few months after surgery for carcinoma cervix.On evaluation, she is found to have a recurrence of the malignancy. Which of the following istrue about her condition?",
      "options": {
        "A": "Most common site of recurrence is pelvic lymph node",
        "B": "Mortality in patients with recurrence is due to pulmonary embolism834",
        "C": "Treatment involves surgery with lymph node dissection",
        "D": "Recurrent tumor with largest diameter &lt;3cm has good prognosis"
      },
      "correct_answer": "D",
      "explanation": "A recurrent tumor with the largest diameter of &lt;3cm is associated with a good prognosis.The extent of recurrent disease and involvement of pelvic lymph nodes are prognostic factors forsurvival. An isolated central pelvic tumour with no involvement of the pelvic sidewall also has agood prognosis.Most recurrences are seen within 3 years and the prognosis is poor with uremia being the mostcommon terminal event. Recurrences most commonly involve the pelvis than the para-aortic orpelvic lymph node.All patients with a suspected recurrence should undergo PET/CT for evaluation and biopsy forconfirmation.Treatment involves either radical chemoradiation or pelvic exenteration. Concurrentchemotherapy with cisplatin and/or 5-fluorouracil may improve the outcome.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 22,
      "question": "Identify the true statement about the staging of cancer cervix.",
      "options": {
        "A": "Clinical examination is the first step in staging",
        "B": "Tumor markers are important for diagnosis of metastasis",
        "C": "CT scan is the best method to assess principal tumors",
        "D": "MRI is the best method to assess nodal metastasis"
      },
      "correct_answer": "A",
      "explanation": "Clinical examination is the first step in staging carcinoma cervix.Clinical examination was the principal method in staging until the 2018 FIGO guidelines whichrecommended the use of imaging and histological investigations when available. USG, CT, MRI,and PET-CT can be used to assess the extent of the tumor, nodal status, and local or systemicspread.MRI is the best method to assess the principal tumor while PET-CT is the best method to assessnodal metastasis.FIGO no longer mandates biochemical investigations, such as tumor markers, for diagnosis ofmetastasis.847",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 23,
      "question": "The CT of a patient with cervical carcinoma revealed a lesion of 6 cm, extending to the upperpart of the vagina and parametrium. What is the stage of the disease?",
      "options": {
        "A": "Stage II A",
        "B": "Stage II B",
        "C": "Stage III A",
        "D": "Stage III B"
      },
      "correct_answer": "B",
      "explanation": "The stage of cervical carcinoma is II B as it involves the upper part of the vagina andparametrium.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 24,
      "question": "A 50-year-old woman presented to her gynecologist with postcoital bleeding. She wasdiagnosed with carcinoma cervix stage IB after evaluation. What is the treatment of choice forthis patient?",
      "options": {
        "A": "Type I hysterectomy",
        "B": "Type II hysterectomy",
        "C": "Type III hysterectomy",
        "D": "Type IV hysterectomy"
      },
      "correct_answer": "",
      "explanation": "Type III hysterectomy is the treatment of choice in carcinoma cervix - stage IB. It involves radicalhysterectomy with pelvic lymphadenectomy and para-aortic lymph node evaluation.Stage IB is defined as a macroscopic lesion still confined to the cervix, with the depth of invasion≥5mm. It is the first stage in which lesions become clinically visible..Hysterectomy types include:• Type I - Simple / extrafascial•• Type II - Modified radical / Wertheim• Type III - Radical / Meigs-Wertheim• Type IV - Extended radical HysterectomyType V - Exenteration.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 25,
      "question": "A 30-year-old woman is found to have a lesion in the cervix which is 7mm wide and has adepth of 4mm. She has one child and wishes to preserve fertility. What is the most835appropriate management?",
      "options": {
        "A": "Cryoablation",
        "B": "Cone biopsy",
        "C": "Radical trachelectomy with pelvic lymphadenectomy",
        "D": "LEEP"
      },
      "correct_answer": "",
      "explanation": "The woman has stage I A2 cervical cancer and the most appropriate management is radicaltrachelectomy with pelvic lymphadenectomy.Radical trachelectomy is a fertility-preserving surgical procedure. This involves the removal of theentire cervix and parametrium.Cervical conization with laparoscopic or extraperitoneal pelvic lymphadenectomy is an alternativethat also preserves fertility.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 26,
      "question": "Which among the following are contraindications for radiotherapy in carcinoma cervix?",
      "options": {
        "A": "1, 2, 3",
        "B": "2, 4, 5",
        "C": "1, 2, 3, 5",
        "D": "1, 2, 4, 5"
      },
      "correct_answer": "",
      "explanation": "Post-menopausal status is not a contraindication for radiotherapy in carcinoma cervix.Contraindications for radiotherapy in carcinoma cervix include:•Pelvic inflammatory disease• Young patient (to preserve ovarian function)• Associated myoma, prolapse, ovarian tumor, genital fistula• Vaginal stenosis• Adenocarcinoma or adenosquamous carcinoma - surgery preferred.848",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Carcinoma Cervix"
    },
    {
      "q_no": 27,
      "question": "You are planning to administer radiotherapy to a 58-year-old woman diagnosed withcarcinoma cervix. What is the dose to be administered at point B?",
      "options": {
        "A": "7000 CGY",
        "B": "6000 CGY",
        "C": "5000 cGy",
        "D": "8000 cGy"
      },
      "correct_answer": "D",
      "explanation": "In the treatment of carcinoma cervix, the dose to be administered at point B is 6000 cGy.Radiotherapy in carcinoma cervix:LocationStructureDosePoint A2cm above and 2cm lateral toexternal osParacervical/Parametrial lymph node7000-8000 cGyPoint B2cm above and 5cm lateral toexternal osObturator lymph node6000 cGyRadiotherapy for carcinoma cervixUterine cavity-Tandem-(with radioactivesource)-2cm3cm↑B7000-8000 cGyExternal os of cervix-2cmOvoids(with radioactivesource)VaginaOMARROW8496000 cGyW",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal2/mcqimage/main/mobgy/exp27_img1_298d8666.jpeg",
      "chapter_heading": "Carcinoma Cervix"
    }
  ]
}